Our findings suggest that TQ modulates Wnt signaling by altering the expression of its core components (WNT7B and WNT6) and regulators (PDE2A and Sema3C), thereby potentially downregulating this oncogenic pathway and contributing to its anti-cancer mechanism in vitro. Here, PDE2A is linked to cancer.